BTK inhibitor 27, also known as BTK inhibitor 1 (Compound 27), is a potent and selective covalent inhibitor of Bruton's tyrosine kinase (BTK). It is a small molecule that has been shown to inhibit the activation of B cells and has potential applications in treating B-cell malignancies and autoimmune diseases.